About CAR-T Cell Therapy
China's NMPA has approved seven CAR-T therapies — more than the US or Europe — including the world's first CAR-T approved for a solid tumour. Quoted per case: drug plus the full treatment course.
Typical cost in China: $89,000–$170,000
Recovery & timeline
Leukapheresis, 2-4 week manufacturing, then 10-14 days inpatient monitoring
Exact recovery depends on your clinical situation; your hospital team will confirm a personalized plan.
Top Hospitals for CAR-T Cell Therapy
Considering CAR-T Cell Therapy in China?
Tell us your diagnosis, scans and timing. We'll match you with the right Grade 3A hospital, confirm the likely cost, and outline the next practical step — free, no commitment.
Start Free Case Review →